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SUMMARY
Engineering commensal organisms for challenging applications, such as modulating the gut 
ecosystem, is hampered by the lack of genetic parts. Here, we describe promoters, ribosome-
binding sites, and inducible systems for use in the commensal bacterium Bacteroides 
thetaiotaomicron, a prevalent and stable resident of the human gut. We achieve up to 10,000-fold 
range in constitutive gene expression and 100-fold regulation of gene expression with inducible 
promoters and use these parts to record DNA-encoded memory in the genome. We use CRISPR 
interference (CRISPRi) for regulated knockdown of recombinant and endogenous gene expression 
to alter the metabolic capacity of B. thetaiotaomicron and its resistance to antimicrobial peptides. 
Finally, we show that inducible CRISPRi and recombinase systems can function in B. 
thetaiotaomicron colonizing the mouse gut. These results provide a blueprint for engineering new 
chassis and a resource to engineer Bacteroides for surveillance of or therapeutic delivery to the gut 
microbiome.
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INTRODUCTION
Bacteroides species are prominent Gram-negative anaerobic symbionts of the mammalian 
gut microbiome (Human Microbiome Project Consortium, 2012), comprising 30% of 
culturable anaerobes in the human gastrointestinal tract (Salyers, 1984). Of the Bacteroides 
genus, Bacteroides thetaiotaomicron is both prevalent (present in 46% of humans) (Human 
Microbiome Project Consortium, 2012) and abundant (up to 1010 per g stool) (Salyers, 
1984), making it a promising organism for both understanding and manipulating the gut 
environment. Stable and robust colonization of the densely populated gut environment is 
facilitated by the metabolic diversity of Bacteroides (Lee et al., 2013). Specifically, B. 
thetaiotaomicron and its relatives are equipped with an extensive repertoire of saccharolytic 
enzymes and serve as primary fermenters of host-, diet-, or microbially-derived 
polysaccharides (Martens et al., 2008). Moreover, members of Bacteroidetes, the phylum to 
which B. thetaiotaomicron belongs, were among the most stable components of the human 
gut microbiota in a 5-year longitudinal study (Faith et al., 2013), making them useful 
candidates for long-term cellular diagnostics and therapeutics in the gastrointestinal tract.
To date, multiple microorganisms have served as chassis for engineered microbial therapies 
of human disease. Recombinant, attenuated strains of Salmonella spp. (Nemunaitis et al., 
2003) and Listeria monocytogenes (Rothman and Paterson, 2013) were used as vectors for 
anti-cancer therapies in several human trials. Lactococcus lactis has been implemented as a 
chassis for the production of therapeutic molecules targeting human inflammatory diseases 
(Steidler et al., 2003). In mouse models, strains of Escherichia coli were engineered to 
produce molecules that reduce food intake and obesity (Chen et al., 2014). However, 
compared to E. coli (Kotula et al., 2014) and L. lactis (Steidler et al., 2003), which undergo 
depletion or clearance within days of administration, Bacteroides populations exhibit low 
variation in abundance and long-term colonization (Lee et al., 2013).
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Genetic parts and circuits enable control over the level and timing of expression of multi-
gene traits in response to environmental conditions. Recently, new techniques in DNA 
construction and high-throughput screening have led to a resurgence in part design, 
including a revisiting of the organization of the “expression cassette” (Leavitt and Alper, 
2015; Nielsen et al., 2013). For model organisms, large libraries and computational models 
of promoters, ribosome binding sites, and terminators enable fine control of multi-gene 
systems (Nielsen et al., 2013). Insulators have been designed for integration between parts to 
ensure that parts can be swapped without impacting function (Brophy and Voigt, 2014; 
Geyer, 1997; Mutalik et al., 2013). However, a challenge with engineering non-model 
organisms has been a lack of these tools, which limits the sophistication of the systems that 
can be constructed (Mutalik et al., 2013).
Few genetic parts and inducible systems are available for B. thetaiotaomicron and its 
relatives. Previous efforts have co-opted natural glycan-sensing systems (Hamady et al., 
2008) or the classic E. coli lac operon (Parker and Smith, 2012) for inducible genetic 
systems, yielding systems that span a 10- to 50-fold range of expression. Replicative 
plasmids (Smith et al., 1992) and integrative transposons (Wang et al., 2000) have been built 
for the introduction of heterologous genes. However, unlike most other prokaryotes, the 
unique major sigma factor in Bacteroides binds to a −33/−7 consensus sequence (TTTG/
TAnnTTTG) (Bayley et al., 2000; Vingadassalom et al., 2005). Moreover, the strength of 
translation initiation is poorly correlated with the level of ribosome binding site (RBS) 
complementarity to the 16S rRNA of the host organism (Wegmann et al., 2013). Compared 
to the E. coli RBS, Bacteroides RBS strength is more sensitive to secondary structures 
(Accetto and Avguštin, 2011), depleted in GC content (Wegmann et al., 2013), and 
predicted to rely more heavily on interactions with ribosomal protein S1. These unique 
promoter and RBS architectures in Bacteroides preclude the direct incorporation of genetic 
systems developed in other organisms (Smith et al., 1992). A lack of genetic part libraries 
hinders the introduction of multi-gene pathways, such as those that could produce a 
metabolic product designed to treat disease.
Multiple cellular states are naturally maintained within Bacteroides populations via 
reversible recombinases that vary expression of cell-surface polysaccharides (Coyne et al., 
2003). Recombinases have been harnessed to build counters and integrated memory-and-
logic devices (Bonnet et al., 2013; Friedland et al., 2009; Siuti et al., 2013; Yang et al., 
2014). By connecting these switches to environmental sensors, cellular memory can be used 
to infer exposure to a particular set of conditions. This is useful if direct readout of a reporter 
from a microenvironment is not possible. For example, an engineered toggle switch enabled 
E. coli to record exposure to antibiotics in the mouse gut (Kotula et al., 2014). In addition to 
toggle switches, memory has recently been achieved using dynamic genome editing 
(Farzadfard and Lu, 2014).
CRISPR-Cas9 technologies have revolutionized genome editing because their ease of 
reprogramming to target user-defined DNA sequences with a single guide RNA (sgRNA) 
(Mali et al., 2013). CRISPR interference (CRISPRi) employs a catalytically inactive version 
of the endonuclease Cas9 (dCas9) to regulate gene expression at target DNA sequences by 
blocking transcription by RNA polymerase (Qi et al., 2013). The specificity of dCas9 
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repression is governed by sequence homology and is independent from host machinery 
(Mali et al., 2013). This has enabled implementation of CRISPRi in both bacterial and 
eukaryotic systems (Qi et al., 2013), permitting both the construction of synthetic gene 
circuits as well as the study of natural biological networks (Nielsen and Voigt, 2014).
Here, we expand the set of genetic tools necessary to precisely and robustly engineer B. 
thetaiotaomicron for microbiome applications. We report a library of biological parts, 
comprised of constitutive promoters, inducible promoters, and RBSs that each span output-
dynamic ranges of several orders of magnitude (Figure 1A). Constitutive promoters and 
RBSs were used to characterize the input expression levels required to generate 
recombinase-based DNA-encoded memory in B. thetaiotaomicron. Externally switchable 
DNA-based memory devices were then constructed by integrating inducible promoters with 
recombinases. Additionally, inducible promoters were used to control CRISPRi-based 
regulation of synthetic and endogenous genes. Finally, we validated the function of these 
tools in bacteria that have colonized the gut of mice. This includes circuits that respond to 
stimuli in vivo and either record exposure by altering gene expression or permanently 
modifying the genome. These devices demonstrate that B. thetaiotaomicron can be used as a 
platform for predictable gene expression and circuit design for microbiome engineering.
RESULTS
Landing Pads for Genetic Part and Device Characterization
All genetic parts in this study were characterized using the integration vector pNBU2 to 
ensure genetic stability of the constructs (Figure 1B). The pNBU2 plasmid encodes the 
intN2 tyrosine integrase, which mediates sequence-specific recombination between the attN 
site of pNBU2 and one of two attBT sites located in the 3′ ends of the two tRNASer genes, 
BT_t70 and BT_t71, on the B. thetaiotaomicron chromosome (Wang et al., 2000). Insertion 
of the pNBU2 plasmid inactivates the tRNASer gene, and simultaneous insertion into both 
BT_t70 and BT_t71, is unlikely due to the essentiality of tRNASer.
Expression Control through Promoter and RBS Design
To expand the range of constitutive gene expression that can be implemented in 
Bacteroides, we constructed and characterized promoter-RBS combinations using the 
NanoLuc luciferase as a reporter (Figures 1B and 1C). Four promoter variants were 
constructed based on the constitutive promoter for the B. thetaiotaomicron housekeeping 
sigma factor BT1311 (PBT1311) (Vingadassalom et al., 2005). Specifically, a 26-bp sequence 
was substituted or inserted into PBT1311 in regions composing and surrounding the −33 and 
−7 promoter sequences (Experimental Procedures; Figure S1), regions known to be 
important for B. thetaiotaomicron promoter activity (Bayley et al., 2000). With NanoLuc as 
a reporter, the PAM promoters spanned a 20-fold range of expression and had decreased 
expression levels relative to the PBT1311 parent promoter. For comparison to prior work, we 
also measured the activities of the previously reported promoter-RBS pairs, PcfxA, PcfiA, P1, 
and PcepA (Goto et al., 2013; Parker and Smith, 1993; Rogers et al., 1994; Wegmann et al., 
2013) (Figure 1D).
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The PAM promoters were then combined with RBSs of varying strength to increase the 
range of expression levels. Previously characterized RBSs GH022, GH023, and GH078 
(Wegmann et al., 2013) have an expression range of less than one order of magnitude 
(Figure 1D). We selected a ribosomal protein RBS (rpiL*) and constructed a weak RBS 
(RC500) to increase the range of our available RBSs (Figure 1D; Experimental Procedures). 
This RBS library spanned a >102-fold range when paired with each PAM-derived promoter. 
When combined, these PAM promoters and RBSs could achieve expression levels over a 
104-fold range.
To identify a set of RBSs for fine-tuning gene expression in B. thetaiotaomicron, we 
generated three randomized rpiL* RBS libraries targeting the most conserved positions of 
the Bacteroides ribosomal protein RBSs (Wegmann et al., 2013). For each library, we 
targeted three nucleotides in and around the rpiL* RBS Shine Delgarno sequence. These 
positions are within or near the RBS region predicted to interact with the ribosomal S1 
protein (nt −21 to −11 relative to the start codon of NanoLuc, Figure 1C) (Boni et al., 1991). 
We achieved 67%–80% coverage of the 64 potential members in each library, resulting in 
142 RBS sequences (Figure 1E; Table S1). These RBSs were screened and sequenced and a 
set of 8 was identified that span 103-fold expression range in approximately even increments 
(Table S2).
We observed only a weak positive correlation between the minimum free energy of RBS 
folding (Experimental Procedures) and expression of the NanoLuc reporter (r2 = 0.19) in the 
rpiL* library (Figure 1F). To visualize the impact of GC content on RBS strength within this 
library, we generated frequency logos for each nucleotide targeted in the library. The 
strongest RBSs were GC-depleted relative to the overall library and the weakest RBSs 
(Figure 1G). Our RBS libraries highlight the distinct AT enrichment of strong Bacteroides 
RBSs compared to other bacterial species, which results in part failure when constructs are 
transferred into Bacteroides from other species (Wegmann et al., 2013).
Genetic Sensors and Inducible Systems
To create inducible systems for use in B. thetaiotaomicron, we adapted parts from the large 
repertoire of systems that govern carbohydrate utilization (Martens et al., 2008). In B. 
thetaiotaomicron, rhamnose metabolism is mediated by the transcriptional activator RhaR, 
which activates transcription at the PBT3763 promoter (Patel et al., 2008). To assay the 
functionality of PBT3763 as an inducible system, we cloned 250 bp of the promoter-RBS 
region upstream of the start codon of BT3763 into the pNBU2 expression vector to drive 
expression of NanoLuc. Gene expression was conditional on the concentration of rhamnose 
and demonstrated a response curve with an output dynamic range of 104-fold (Figure 2A). 
Fitting the response curve to a Hill function revealed a threshold K of 0.3 mM and a Hill 
coefficient n = 1.4.
Two-component systems are signal-transduction mechanisms widespread in bacteria for 
sensing external stimuli. Bacteroides sp. possess a unique variant of these systems, called 
hybrid two-component systems, that incorporate both the sensor histidine kinase and 
response regulator of classical two-component systems into a single polypeptide chain 
(Sonnenburg et al., 2006). Putative hybrid two-component systems, BT3334 and BT0267, 
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were identified in transcriptomic studies to control expression of the chondroitin sulfate 
(ChS)-inducible PBT3324 promoter and arabinogalactan (AG)-inducible PBT0268 promoter, 
respectively (Martens et al., 2008, 2011). Chondroitin sulfate induction of PBT3324 and 
arabinogalactan induction of PBT0268 led to a 60-fold and 29-fold regulation of output gene 
expression, respectively (Figures 2B and 2C).
Next, we developed an isopropyl β-D-1-thiogalactopyranoside (IPTG)-inducible system 
based on the E. coli LacI system. Our design expands upon on a previously developed 
IPTG-inducible system in Bacteroides (Parker and Smith, 2012) by investigating the 
position effects of operator sites on gene expression. Pairs of LacO1 operator sites were 
inserted in the strong PcfxA promoter in three locations (Figures 2 and S2), and the LacI 
repressor was expressed from the BT1311 promoter. Compared to the unmodified PcfxA 
promoter, the addition of synthetic operator sites diminished the maximum expression of 
NanoLuc (Figure S2). This strategy produced two IPTG-inducible promoters that with 
thresholds at K = 86 µM (PLacO13) and K = 6 µM (PLacO23). The induction of these systems 
elicited an 8- and 22-fold change in gene expression, respectively (Figure 2D).
As the orthogonality of genetic parts is crucial for their simultaneous use, we tested the 
degree of cross-talk between each inducible system by incubating each engineered strain 
with the full set of carbohydrate inducers. The inducers themselves bear little structural 
similarity: rhamnose, a methyl-pentose sugar; ChS, a sulfated glycosaminoglycan composed 
of chains of acetylgalactosamine and glucuronic acid residues; AG, a polysaccharide 
composed of arabinose and galactose units; and IPTG, a molecular mimic of allolactose. 
Functionally, each inducible system was highly orthogonal to each other, with no cross-
reactivity observed with any of the combinations (Figure 2E).
Synthetic Genetic Memory
To equip B. thetaiotaomicron with permanent genetic memory, we used serine integrases, 
which catalyze unidirectional inversion of the DNA sequence between two recognition 
sequences (Figure 3A) (Grindley et al., 2006). Recently, 11 orthogonal integrases and their 
recognition sequences were characterized in E. coli (Yang et al., 2014), and a DNA 
“memory array” composed of a linear concatenation of integrase recognition sequences was 
used to record the expression of one or multiple integrases in response to a stimulus.
We identified serine integrases that function in B. thetaiotaomicron by cloning the integrases 
into a strong constitutive expression vectors (PAM4-rpiL*, 1.2 × 10−2 RLU/CFU). To 
provide a stable, single-copy record of DNA inversion, we incorporated the DNA memory 
array containing the integrase recognition sequences into the B. thetaiotaomicron 
chromosome (Figures 3B and 3C; Experimental Procedures). Integrase expression vectors 
were conjugated into the B. thetaio taomicron memory array strain. Genomic DNA was 
isolated from transconjugants and analyzed by PCR to detect flipping. Four integrases, Int7, 
Int8, Int9, and Int12, each catalyzed recombination at the respective recognition sequence in 
the memory array (Figure 3D), and DNA inversion was not detected in the absence of an 
integrase (Figure S3A).
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To create an inducible memory switch, we cloned Int12 under the control of the rhamnose-
inducible promoter with the rpiL*RBS variant C51 (Figures 1E and 3E; Table S1). The 
Int12 recombinase switch responded to increasing concentrations of rhamnose (Figure 3F) 
within 2 hr (Figure 3G), with no background detected in the absence of inducer. Notably, 
expression of Int12 did not impact growth of B. thetaiotaomicron, even when maximally 
expressed (Figure S3B).
CRISPRi-Mediated Gene Knockdown
CRISPRi can provide a facile toolbox for constructing synthetic gene circuits and 
modulating endogenous genes in B. thetaiotaomicron. To demonstrate the use of CRISPRi-
mediated gene knockdown for synthetic constructs, production of dCas9 was regulated by 
the IPTG-inducible PLacO23 system. sgRNAs were constitutively expressed from the P1 
promoter and were designed to target the coding sequence of NanoLuc (NL1–4) or the PcfiA 
promoter (PR1–2) (Figure 4A). A nonsense sgRNA (NS) with no sequence identity to either 
PcfiA or NanoLuc was used as a negative control. All specifically targeted sgRNAs repressed 
the expression of NanoLuc (Figure 4B) by 20- to 45-fold with IPTG induction of dCas9 
expression (Figure 4C), thus implementing genetic NOT gates in B. thetaiotaomicron. The 
IPTG-to-NanoLuc response function of sgRNAs targeting the coding sequence or promoter 
exhibited similar Hill coefficients and lower dissociation constants to the IPTG-to-NanoLuc 
transfer function of the PLacO23 promoter on its own (n = 1.1–1.4; K = 0.6–1.4 µM IPTG).
To demonstrate the programmable knockdown of endogenous genes in B. thetaiotaomicron, 
we designed sgRNAs to target mechanisms implicated in the resilience of Bacteroides in the 
human microbiota. In B. thetaiotaomicron, LpxF, the gene product of BT1854, is required 
for resistance to inflammation-associated cationic antimicrobial peptides, such as polymyxin 
B (Cullen et al., 2015). Using the minimum inhibitory concentration (MIC) of polymyxin B 
as a phenotypic readout, we designed an sgRNA to specifically suppress BT1854 
expression. In cells containing the sgRNA targeted against BT1854 (dCas9BT1854), the 
induction of dCas9 with led to sensitization of the cells to polymyxin B treatment (8- to 16-
fold decrease in MIC), while wild-type B. thetaiotaomicron and strains containing dCas9NS 
demonstrated high levels of polymyxin B resistance in the presence or absence of dCas9 
induction with IPTG (Figures 4D and 4E).
Next, we explored dCas9-mediated repression of carbohydrate-utilization pathways in B. 
thetaiotaomicron, which are important for the bacterium’s ability to successfully and 
persistently colonize the mammalian gut. The hybrid two-component sensor BT1754 
regulates the BT1757-1763/BT1765 fructose-containing polysaccharide utilization locus, 
and BT1754 is essential for growth on fructose as the sole carbon source (Sonnenburg et al., 
2010). We designed a specific sgRNA to repress BT1754 and integrated this system into the 
B. thetaiotaomicron genome along with an IPTG-inducible dCas9 cassette (dCas9BT1754) 
(Figures 4D and 4F). Induction of dCas9BT1754 did not affect the growth rate of cells on 
minimal media (MM)-glucose compared to WT cells and dCas9NS. The generation time G = 
(log102 × t)/log10(B/B0) ≈ 1 hr (where t is the time interval, and B0 and B are the initial and 
final concentrations of bacteria, respectively), indicating that neither dCas9 induction nor 
repression of BT1754 impacts growth on glucose media (Figure 4F). However, induction of 
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dCas9BT1754 drastically decreased the growth rate of the cells in MM-fructose (G = 4.7 hr) 
while the growth of WT and dCas9NS cells in MM-fructose remained similar (G = 1 hr) to 
growth in MM-glucose (Figure 4F). Thus, inducible dCas9-mediated repression of 
endogenous genes can alter both the resistance and metabolic profiles of B. 
thetaiotaomicron.
Function of Genetic Parts in B. thetaiotaomicron Colonizing the Mouse Gut
We next investigated whether the function of our B. thetaiotaomicron genetic parts and 
modules can be maintained in the context of a complex microbiota. As wild-type strains of 
Bacteroides spp. are unable to stably colonize conventional specific-pathogen-free (SPF) 
mice (Lee et al., 2013; Cullen et al., 2015), we employed an antibiotic regimen that 
promotes B. thetaiotaomicron colonization without sterilizing the gut microbiota (Figure 
5A) (Bloom et al., 2011; Lee et al., 2013). A 10-day treatment of animals with ciprofloxacin 
and metronidazole prior to bacterial inoculation was sufficient to maintain stable and high 
levels of colonization for the duration of the experiments (up to 12 days tested) (Figure S4).
Using this model, we tested the functionality of our inducible systems, CRISPRi, and 
integrases in vivo. First, SPF mice were colonized with the strain containing the 
arabinogalactan-inducible PBT0268 promoter-driving expression of NanoLuc (Figure S4A). 
Within a day of addition of arabinogalactan to the drinking water of the mice, luciferase 
activity in fecal pellets increased ~75-fold (Figure 5B). Following removal of inducer from 
the drinking water, luciferase activity in the fecal pellets of mice fed inducer rapidly 
returned to baseline, demonstrating tight temporal control of gene expression dependent on 
arabinogalactan.
To investigate whether more complex genetic circuits perform in the context of the mouse 
microbiome, we evaluated the dCas9NL3 repressor cascade, which is composed of the 
CRISPRi system as well as the PLacO23 IPTG-inducible promoter, within stably colonized B. 
thetaiotaomicron. Within 24 hr of adding IPTG to drinking water, CRISPRi elicited an ~20-
fold reduction in gene expression compared to the uninduced control (Figure 5C). The fold 
repression observed in vivo is similar to that measured in vitro. Luciferase activity returned 
to baseline 6 days following the removal of IPTG from drinking water. Moreover, 
expression of dCas9 and NanoLuc did not significantly impact in vivo fitness compared to 
uninduced controls (Figures S4A and S4B).
To test the function of recombinases in vivo, we colonized mice with a B. thetaiotaomicron 
strain containing the rhamnose-inducible Int12 integrase memory switch (Figure 3E). All 
mice were fed with plant-based chow that was determined to be composed of 0.3% 
rhamnose (w/w). In addition, after 1 day of colonization, the drinking water of half of the 
mice was supplemented with 0.5 M rhamnose to further induce the memory switch. Stool 
was collected over the course of the experiment, and the absolute number of unflipped 
(wild-type) and flipped Int12 recognition sequences was determined by qPCR (Figure 5D; 
Experimental Procedures). A background recombination rate of ~11% per day was detected 
in mice fed on rhamnose-containing chow but not supplemented with rhamnose in their 
drinking water (Figure 5D, “Chow”). In mice supplemented with exogenous rhamnose 
(Figure 5D, “Chow + Rha”), the recombinase switch achieved >90% flipping in % 1 day, a 
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statistically significant increase over mice not supplemented with rhamnose in the water (p < 
0.01; Figure 5D).
DISCUSSION
Here, we developed a versatile set of genetic technologies for the manipulation of the 
abundant gut symbiont B. thetaiotaomicron. Given the distinct transcriptional and 
translational control mechanisms in B. thetaiotaomicron, we laid the foundation for circuit 
design in B. thetaiotaomicron by identifying promoters and RBSs for this organism through 
literature searches and library construction. The resulting toolbox expanded upon the 
number and expression range of genetic parts available for Bacteroidetes (previous range: 
102) (Accetto and Avguštin, 2011; Hamady et al., 2008; Parker and Smith, 2012; Wegmann 
et al., 2013) and achieved ranges of expression similar to those of libraries characterized for 
other gut-associated bacteria, including E. coli (range: 104–105) (Cox et al., 2007; Kosuri et 
al., 2013; Salis et al., 2009) and lactic acid bacteria (range: 103) (Jensen and Hammer, 1998; 
Kleerebezem et al., 1997). Using a similar approach, we characterized four orthogonal-
inducible expression systems. This library of B. thetaiotaomicron promoters and RBSs 
enabled us to import host-independent machinery, dCas9 and serine integrases, to implement 
more complex circuits. We envision that similar approaches, coupled with continuing 
advances in DNA sequencing and synthesis technologies, will enable the rapid and large-
scale porting of genetic parts and devices from model organisms into new chassis that can 
address real-world applications. Lastly, we demonstrated the functionality of these genetic 
parts in the context of the mouse microbiome. Future work will focus on scaling the 
complexity of genetic circuits that can be implemented in commensal bacteria and pursuing 
long-term and quantitative control of microbial and mammalian host biology in vivo.
For microbiome engineering applications, the ability to precisely modulate gene expression 
in commensal organisms should enable functional studies of the microbiome, non-invasive 
monitoring of in vivo environments, and long-term targeted therapeutics. For example, our 
constitutive and inducible systems, integrases, and CRISPRi regulators could be integrated 
for higher-order computation in B. thetaiotaomicron, such as digital logic, memory, and 
analog circuits. These engineered commensals could be used to map the dose-dependent and 
temporal effects of specific surface polysaccharides (Liu et al., 2008) or heterologous 
pathways (Claesen and Fischbach, 2015) on colonization and maintenance of the gut 
microbiota and on host health. Higher-order combinations of inducible promoters linked 
with integrases could achieve Boolean logic with embedded cellular memory (Siuti et al., 
2013), enabling surveillance of the gut environment. Furthermore, environmental sensing 
with analog circuits (Daniel et al., 2013) coupled with precision expression control of 
heterologous pathways in B. thetaiotaomicron could be exploited for on-demand, localized, 
and rheostatic delivery of therapeutic molecules. We have also shown that the CRISPRi 
system can be used to dynamically manipulate bacterial processes in B. thetaiotaomicron by 
targeting endogenous genes. dCas9-mediated repression could be induced in a commensal 
library of B. thetaiotaomicron harboring distinct guide RNAs to identify genes required for 
B. thetaiotaomicron maintenance (Sonnenburg et al., 2010) or interspecies interactions 
(Mahowald et al., 2009). With these genetic resources, we envision that B. thetaiotaomicron 
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will be a useful platform for cellular sensing, computation, and actuation at the host-microbe 
interface in the gut.
EXPERIMENTAL PROCEDURES
Bacterial Strains and Culture Conditions
B. thetaiotaomicron VPI-5482 (ATCC 29148) (GenBank: AE015928.1) was used for all 
studies except for the integrase-based memory units. B. thetaiotaomicron VPI-5482 Δtdk 
was used for the insertion of the memory array and the characterization of integrases.
Genetic Parts and Plasmids
Genetic parts and plasmids used in this study are listed in Tables S3 and S4 and will be 
publically available and deposited in Addgene upon publication. Single guide RNAs 
(sgRNA) used in this study are listed in Table S5. pNBU2 constructs were conjugated into 
B. thetaiotaomicron from E. coli. The DNA memory array cassette (Yang et al., 2014) was 
introduced into the chromosome of a B. thetaiotaomicron Δtdk strain by allelic exchange 
(Supplemental Experimental Procedures).
Construction of Promoter and RBS Libraries
Promoters and RBS libraries were constructed by PCR using primers with specific or 
degenerate sequences (Supplemental Experimental Procedures).
Luciferase Assay
NanoLuc luciferase assay was performed with cell lysates or fecal suspensions according to 
the manufacturer’s suggestions (Supplemental Experimental Procedures). Luciferase 
activities were measured with an integration time of 1 s at a gain setting of 100 in a BioTek 
Synergy H1 Hybrid Reader.
Construction and Analysis of the rpiL* RBS Library
The rpiL* RBS was mutagenized by amplifying the plasmid pAT593 (encoding PBT1311-
rpiL*-NanoLuc in a pNBU2 vector) with primer oAT617 in combination with primer 
oAT614, primer oAT615, or primer oAT616 (Table S6), which were each synthesized with 
degenerate nucleotides at three positions (43 = 64 potential members in each library). The 
resulting fragments were digested with BbsI, ligated with T4 ligase, and digested with DpnI, 
yielding three scarless PBT1311-rpiL* RBS libraries.
Growth and Induction
For inducible promoter and dCas9 assays, overnight cultures were diluted 1:100 in fresh 
tryptone yeast extract glucose medium (TYG) supplemented with inducer. The inducers 
used were IPTG (Goldman), L-rhamnose (Sigma), chondroitin sulfate A from bovine 
trachea (Sigma), (+)-arabinogalactan from larch wood (TCI), and fucose (Sigma). Cultures 
were grown anaerobically at 37°C to an optical density (OD600) of ~0.4–0.8 (~5 hr) before 
assaying luciferase activity.
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In Vitro Genetic Memory Assays
To identify integrases that function in B. thetaiotaomicron, pNBU2-based plasmids 
containing PAM4-rpiL*RBS-integrase combinations were conjugated into B. 
thetaiotaomicron Δtdk harboring a chromosomal copy of the memory array. Cells were 
plated on BHIS+Gm+Erm to select for strains that contained the promoter-RBS-integrase 
plasmids. DNA was isolated from transconjugants were grown were assayed by PCR for 
inversion of spacer sequences in the memory array cassette as described (Yang et al., 2014). 
Control primers specific for unflipped (wild-type) memory array were used to detect the 
wild-type orientation of the spacer sequences (Table S6).
To characterize the function of integrase Int12 in B. thetaiotaomicron, a pNBU2-based 
plasmid containing PBT3763-rpiL*C51RBS-Int12 was constructed and conjugated into B. 
thetaiotaomicron memory array strain described above. For the recombinase response curve, 
an overnight culture grown in TYG was diluted (1:100) into TYG or TYG supplemented 
with rhamnose and grown for 8 hr at 37°C. The final OD600 of each culture was measured 
using a Cary 50 UV-Vis spectrophotometer (Varion), and 500 µl of each cell culture was 
harvested by centrifugation, flash frozen, and stored at −80°C until DNA was extracted. For 
the recombinase time course assay, cells were grown in TYG supplemented with 10 mM 
rhamnose for 8 hr at 37°C, harvested periodically, and stored as described above. DNA was 
isolated using the DNeasy Blood and Tissue Kit (QIAGEN). Levels of integrase-mediated 
recombination in vitro were quantified using qPCR with specific to the wild-type 
(unflipped) (oAT836/837) or recombined (flipped) (oAT836/838) DNA at the target 
sequence. For absolute quantitation, we used a standard curve generated with purified DNA 
standards. Flipping ratio was calculated as (copies of flipped DNA)/(copies of flipped DNA 
+ copies of unflipped DNA).
Polymyxin B Susceptibility
Minimum inhibitory concentrations (MICs) were determined by broth microdilution using 
TYG broth according to modified Clinical and Laboratory Standards Institute (CLSI) 
guidelines (Supplemental Experimental Procedures).
Fructose/Glucose Growth Assay
Overnight cultures were grown in TYG supplemented with or without 100 µM of IPTG. The 
following morning, samples were diluted 1:100 in MM supplemented with either 0.5% 
glucose or 0.5% fructose as the sole carbon source and with or without 100 µM IPTG. 
Cultures were incubated anaerobically at 37 °C and 200 µl samples were withdrawn from 
the cultures every hour for 10 hr to monitor growth (OD600) in a BioTek Synergy H1 Hybrid 
Reader.
Animals
All animal study protocols were approved by the MIT Animal Care and Use Committee. 
Specific-pathogen-free (SPF) female Swiss Webster mice (5–8 weeks) were purchased from 
Charles River and were housed and handled in non-sterile conditions. Mice were fed 
irradiated mouse chow (PicoLab Rodent Diet 20, LabDiet) and provided autoclaved or 
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sterile filtered water for the duration of the experiment. Prior to bacterial gavage, mice were 
administered ciprofloxacin HCl (0.625 g/l), metronidazole (1 g/l) in sugar-sweetened 
drinking water for 7 days and were subsequently treated with metronidazole (100 mg/kg) by 
oral gavage every 24 hr and ciprofloxacin (0.625 g/l) dissolved in drinking water for 3 days. 
Animals were transferred to a clean cage and provided fresh medicated water on the fifth 
day of the antibiotic regimen. Two days after the cessation of antibiotic treatment, animals 
were inoculated with engineered strains of B. thetaiotaomicron (~5 × 108 CFU/mouse) by 
oral gavage. Mice belonging to the same treatment group were cohoused for the duration of 
the experiment. Fecal pellets were collected daily for luciferase and qPCR analysis 
(described below).
Enumeration of B. thetaiotaomicron Strains In Vivo
Strains were enumerated by qPCR with strain-specific primers (Table S6) targeting the 
NanoLuc (mmD662/663) or flipped (oAT836/838)/unflipped (oAT836/837) memory array 
alleles in total fecal DNA. For absolute quantitation, we used a standard curve generated 
with purified DNA standards.
Function of Inducible Promoters and CRISPRi In Vivo
After collection of stool 2 days post-bacterial gavage, mice were provided drinking water 
supplemented with 25 mM IPTG, 5% arabinogalactan, or kept on sterile water as controls. 
Normal drinking water was returned to animals 4 days post-bacterial gavage. For the 
arabinogalactan experiment, animals were transferred to a clean cage following removal of 
supplemented drinking water. For the CRISPRi experiment, animals were transferred to a 
clean cage 7 days post-bacterial gavage. Luciferase values were measured daily and 
normalized to the cell density by determining the copy number of NanoLuc by qPCR using 
primers mmD662/663.
Quantification of Memory Unit Recombination In Vivo
After collection of stool on Day 1, mice were provided with drinking water supplemented 
with 0.5 M rhamnose or were maintained on sterile water as controls. Mice were transferred 
to clean cages and returned to normal drinking water 3 days post-bacterial gavage. Levels of 
integrase-mediated recombination in vivo were determined by analyzing fecal DNA (1 µl) 
by qPCR with primers as described for the in vitro analysis. Flipping ratio was calculated as 
(copies of flipped DNA)/(copies of flipped DNA + copies of unflipped DNA).
Data Analysis, Statistics, and Computational Methods
All data were analyzed using GraphPad Prism version 6.05 (GraphPad Software, http://
www.graphpad.com/). Error bars represent the SD of three experiments carried out on 
different days. Fold repression was calculated by dividing the luminescence of uninduced 
samples (RLU/CFU) by the luminescence of samples treated with maximum inducer 
concentration. All response curves were fit to a Hill function: Y = (BmaxXn)/(Kn+Xn) + C, 
where X is the input, Y is the output, Bmax is the maximum luminescence, n is the Hill 
coefficient, K is the threshold, and C is baseline luminescence. RBS frequency logos were 
generated for the region of the rpiL* RBS targeted by mutagenesis by comparing the 
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frequency of each nucleotide at each position within the subpopulation (strongest 7% of 
RBSs and weakest 7% of RBSs) to the frequency of that nucleotide at that position in the 
full library.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Highlights
• We develop sets of genetic parts for a human commensal bacterium
• Promoter and RBS libraries control gene expression over a 10,000-fold dynamic 
range
• Orthogonal, inducible sensors enable synthetic genetic memory and CRISPRi
• Genetic circuits respond to stimuli in a complex mouse gut microbiota
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Figure 1. Genetic Parts to Control Expression in B. thetaiotaomicron
(A) The ranges of gene expression are shown for the different gene regulation systems 
developed in this manuscript. AG, arabinogalactan; CS, chondroitin sulfate; IPTG, isopropyl 
beta-D-1-thiogalactopyranoside; Rha, rhamnose; dCas9, catalytically inactive Cas9 
endonuclease
(B) Tyrosine integrase IntN2 catalyzes stable integration of pNBU2-based expression 
constructs into one of two attBT2 sites in the B. thetaiotaomicron genome (Wang et al., 
2000). The two attBT2 sites (attBT2-1 at nt 6,217,227 and attBT2-2 at nt 6,138,320) are in 
the 3′ ends of tRNASer genes (BT_t71 and BT_t70, respectively). ApR, ampicillin resistance 
cassette; ErmR, erythromycin resistance cassette; RP4, origin of transfer; R6K, origin of 
replication; NanoLuc, luciferase
(C) Constitutive promoters and ribosome binding sites for the construction of gene 
expression libraries. The putative −33 and −7 regions of the PBT1311 promoter, the Shine-
Delgarno sequence, and the start codon are indicated by black boxes. Numbers below the 
black boxes represent nucleotide locations relative the PBT1311 transcription start site. The 
26 bp sequence introduced in the PAM promoters is shown as blue boxes (see also Figure 
S1). Numbers at the edges of the blue boxes indicate the PBT1311 nucleotides replaced or the 
insertion site within the promoter. The location of residues randomized in the rpiL* RBS 
library are indicated with red arrows (for library A: nt −14, −13, −12; for library B: nt −21, 
−18, −15; and for library C: nt −17, −16, −11; nt numbering is relative to the translation start 
site).
(D) Activity was measured for a set of constitutive promoters and their cognate RBSs. For 
PAM1, PAM2, PAM3, PAM4, the BT1311 RBS was used. Furthermore, PBT1311, PAM1, PAM2, 
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PAM3, and PAM4 were combined with RBSs of varying strengths. Gene expression was 
measured using a luciferase reporter (NanoLuc) and reported as relative light units/colony 
forming unit (RLU/CFU).
(E) Three large RBS libraries were constructed and combined with promoter PBT1311. For 
reference, the parent rpiL* RBS is indicated with a red arrow. The sequences of the RBSs 
are provided in Table S1. For (D) and (E), error bars represent the SD of three independent 
biological replicates made on separate days.
(F) The strength of each RBS was compared to the predicted free energy of folding for the 
mRNA (ΔGfold).
(G) A consensus strong RBS and weak RBS were generated for the rpiL* RBS library using 
frequency logos that included the 11 strongest and 11 weakest RBSs (residue locations are 
stated relative to the translation start site). Frequency logos were constructed by comparing 
the frequency of each nucleotide at each position in that group with the frequency of that 
nucleotide in that position in the full library. Position −20 and −19 were not randomized and 
are not shown in the frequency logos.
See also Tables S1 and S2.
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Figure 2. Design and Characterization of Genetic Sensors
(A–D) Response curves for NanoLuc under the regulated control of the rhamnose (Rha)-
inducible promoters (A), chondroitin sulfate (ChS)-inducible promoters (B), arabinogalactan 
(AG)-inducible promoters (C), or IPTG-inducible promoters (D). LacO1 operator sites were 
inserted in various regions (O1, O2, O3) of the PcfxA promoter (see also Figure S2). For (D), 
squares indicate PLacO23 and circles indicate PLacO13. Inducer concentrations were applied 
as follows: 3-fold serial dilutions starting at 10 mM Rha (A); 3-fold serial dilutions starting 
at 0.4% for ChS (B) and AG (C); and 4-fold serial dilutions starting at 500 µM for IPTG 
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(D). The leftmost data point in each plot represents the background luminescence in the 
absence of inducer. Response curves were fit to a Hill function (solid lines).
(E) Orthogonality matrix of sugar-inducible genetic systems incubated with 10 mM 
rhamnose (Rha), 0.2% chondroitin sulfate (ChS), 0.2% arabinogalactan (AG), or 100 µM 
IPTG compared to no inducer. Error bars represent the SD of three biological replicates 
made on different days.
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Figure 3. Synthetic Genetic Memory
(A) Integrases mediate recombination of DNA between integrase binding sites (attB/attP), 
resulting in the inversion of the intervening spacers.
(B) Schematic of the location of the promoter-RBS-integrase system and the memory array 
cassettes in the B. thetaiotaomicron chromosome.
(C) Integrase-mediated DNA inversion at each integrase target sequence in the memory 
array cassette is detected by PCR. Primer pairs (arrows) anneal to the interface of the 
integrase recognition sites and to the spacer region between recognition sites. PCR 
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amplification occurs only after an inversion event (solid lines below the primer arrows 
indicate expected amplicons).
(D) Representative PCR products are shown after recombination with integrases Int7, Int8, 
Int9, or Int12. – indicates no integrase, + indicates the integrase is present. PAM4-rpiL* was 
used to control expression of each integrase (see also Figure S3.)
(E) Schematic of the rhamnose-inducible recombinase circuit. Transcriptional activator 
RhaR, produced from the endogenous locus, is activated in the presence of rhamnose 
causing expression of Int12 from PBT3763. Int12 mediates recombination between the Int12 
attB and attP recognition sequences.
(F) Response curve of Int12 memory circuit. Int12 was placed under the control of a subset 
of PBT3763-rpiL*C51. Inducer concentrations were 9-fold serial dilutions starting at 10 mM 
rhamnose. The leftmost data point represents the recombination in the absence of inducer. 
Cells were grown 8 hr at 37°C before harvesting cells and isolating DNA. Absolute 
quantities of flipped and unflipped memory array in genomic DNA were determined by 
qPCR using standard curves (Experimental Procedures). The recombination ratio is 
expressed as the ratio of cells containing a flipped memory array (Flipped) divided by the 
sum total of cells containing a flipped or unflipped array (Total). Data were fit with a Hill 
function to guide the eye (see also Figure S3).
(G) Int12-mediated recombination versus time. Cells were induced with 10 mM rhamnose at 
t = 0. Absolute quantities of flipped and unflipped memory array in genomic DNA were 
determined by qPCR using standard curves (Experimental Procedures). Recombination 
ratios were determined as in (F). Data were fit with a sigmoidal dose-response function to 
guide the eye. For (F) and (G), error bars represent the SD of three biological replicates 
made on different days. See also Figure S3.
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Figure 4. CRISPRi-Mediated Repression of Recombinant and Endogenous Genes
(A) Schematic of dCas9-based repression of NanoLuc. Addition of IPTG induces expression 
of dCas9, which complexes with constitutively expressed sgRNA targeting the coding 
sequence of NanoLuc (NL1–4) or the PcfiA promoter (PR1–2). The plasmid backbone 
separates the NanoLuc cassette and the IPTG-inducible CRISPRi system.
(B) Response curves of dCas9-mediated targeting the coding sequence of NanoLuc (NL1–
4), the promoter (PR1–2) or a nonsense sequence (NS). Fourfold serial dilutions of IPTG 
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starting at 500 µM or no inducer were added to cultures. Response curves were fit to a Hill 
function (solid lines).
(C) Fold repression elicited by various gRNAs in the presence (500 µM) of inducer. Bars are 
colored to correspond to (B).
(D) Genomic location of endogenous genes targeted using CRISPRi.
(E) Minimum inhibitory concentrations (MICs) of polymyxin B for cells with CRISPRi 
targeted against BT1854 (dCas9BT1854) compared with wild-type (WT) cells or non-specific 
control cells (dCas9NS). Reported values are the mode of three independent biological 
replicates made on three separate days.
(F) CRISPRi was targeted against BT1754 (dCas9BT1754). Growth curves of wild-type (WT) 
(black), dCas9BT1754 (pink), or dCas9NS (gray) cells in minimal media supplemented with 
0.5% glucose (MM-Glc) or 0.5% fructose (MM-Fru) in the presence (full line) or absence 
(dotted line) of 100 mM IPTG. Error bars represent the SD of three biological replicates 
made on different days.
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Figure 5. In Vivo Function of Genetic Parts within B. thetaiotaomicron Colonizing the Mouse 
Gut
(A) Experimental timeline. Specific-pathogen-free (SPF) Swiss Webster mice were treated 
for 10 days with ciprofloxacin and metronidazole and gavaged with B. thetaiotaomicron 2 
days after cessation of treatment. Bacterial gavage was administered on Day 0 (B–D).
(B and C) Luciferase activity in fecal pellets of mice inoculated with strains possessing the 
arabinogalactan (AG)-inducible PBT0268 (B) or IPTG-inducible CRISPRi dCas9NL3 (C) 
systems. Mice were provided drinking water supplemented with 5% arabinogalactan (B) 
(solid line), or 25 mM IPTG (C) (solid line) for 2 days after stool collection on Day 2 (gray 
box), or were maintained on normal drinking water throughout the entire experiment 
(dashed lines). Inducer water was removed on Day 4 after stool collection. Luminescence 
values were normalized to cell density as determined by qPCR using NanoLuc-specific 
primers.
(D) SPF mice were colonized with B. thetaiotaomicron containing the rhamnose-inducible 
integrase construct PBT3763-rpiL*C51-Int12. All mice were exposed to 0.3% rhamnose 
(w/w) in the plant-based chow. In addition, half of the mice had their drinking water 
supplemented with 500 mM rhamnose after stool collection on Day 1 (“Chow + Rha,” solid 
line) while the other half of the mice were maintained on normal drinking water throughout 
the entire experiment (“Chow,” dashed line). Mice receiving rhamnose-supplemented water 
on Days 1 and 2 (gray box) were returned to normal water on Day 3 after stool collection. 
Recombination ratios were determined for fecal DNA as described in Figure 3F. For day 3 
“Chow” samples, n = 3. For all other days, n = 6 for both treatment groups. See also Figure 
S4. For (B)–(D), individual points represent independent biological replicates and the line 
represents the mean of the group. *p < 0.05, **p < 0.01.
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